alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 66, Number 33 (Friday, February 16, 2001)]
[Notices]
[Page 10672]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-4074]


=======================================================================
-----------------------------------------------------------------------

DEFENSE NUCLEAR FACILITIES SAFETY BOARD


Meeting; Sunshine Act

    Pursuant to the provision of the ``Government in the Sunshine Act'' 
(5 U.S.C. Sec. 552b), notice is hereby given of the Defense Nuclear 
Facilities Safety Board's (Board) meeting described below.

TIME AND DATE OF MEETING: 9 a.m., February 22, 2001.

PLACE: The Defense Nuclear Facilities Safety Board, Public Hearing 
Room, 625 Indiana Avenue, NW., Suite 300, Washington, DC 20004.

STATUS: Open.

MATTERS TO BE CONSIDERED: The Defense Nuclear Facilities Safety Board 
(``Board'') will reconvene and continue the fourteenth quarterly open 
meeting conducted on February 13, 2001, regarding the status of 
progress of the activities associated with the Department of Energy's 
Implementation Plans for the Board's Recommendation 95-2, Integrated 
Safety Management (``ISM''), Recommendation 98-1, Integrated Safety 
Management (Response to Issues Identified by the Office of Internal 
Oversight), and Recommendation 2000-2, Configuration Management, Vital 
Safety Systems. Topics will include the roles of line management in 
executing these Implementation Plans and the budgetary resources 
required to satisfy the Department's commitments.

CONTACT PERSON FOR MORE INFORMATION: Richard A. Azzaro, General 
Counsel, Defense Nuclear Facilities Safety Board, 625 Indiana Avenue, 
NW., Suite 700, Washington, DC 20004, (800) 788-4016. This is a toll-
free number.

SUPPLEMENTARY INFORMATION: The Defense Nuclear Facilities Safety Board 
reserves its right to further schedule and otherwise regulate the 
course of this meeting, to recess, reconvene, postpone or adjourn the 
meeting, and otherwise exercise its authority under the Atomic Energy 
Act of 1954, as amended.

    Dated: February 13, 2001.
John T. Conway,
Chairman.
[FR Doc. 01-4074 Filed 2-13-01; 4:41 pm]
BILLING CODE 3670-01-P
##### 



Exhibit 32.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Opinion Research Corporation (the Company) on Form 10-K
for the fiscal year ending December 31, 2004, as filed with the Securities and Exchange Commission
on the date hereof (the Report), I, Douglas L. Cox, Executive Vice President and Chief Financial
Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that: (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and (2) the information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company. Date:    March 31, 2005
    Signed:
    /s/ Douglas L. CoxName:
    Douglas L. CoxTitle:
    Executive Vice President and Chief
Financial Officer
EXHIBIT 32.1


                                  CERTIFICATION

Pursuant to 18 U.S.C.  Section 1350, I, Andrew J. Mako, Chief Executive  Officer
and President of Pruco Life Insurance Company of New Jersey, hereby certify that
the  accompanying  Quarterly Report on Form 10-Q for the quarter ended September
30,  2004,  containing  the  financial  statements  of Pruco  Life of New Jersey
Variable  Contract  Real  Property  Account  (a  separate  account of Pruco Life
Insurance  Company of New  Jersey) and The  Prudential  Variable  Contract  Real
Property  Partnership  (the "Report"),  fully complies with the  requirements of
Section  13 (a) or 15 (d) of the  Securities  Exchange  Act of 1934 and that the
information  contained in the Report fairly presents,  in all material respects,
the  financial  condition  and results of operations of Pruco Life of New Jersey
Variable  Contract Real Property  Account and The Prudential  Variable  Contract
Real Property Partnership.

Date: November 15, 2004

/s/ Andrew J. Mako
---------------------

Name: Andrew J. Mako
Title: Chief Executive Officer and President

The foregoing  certification  is being  furnished  solely  pursuant to 18 U.S.C.
Section  1350 and is not  being  filed as part of the  Report  or as a  separate
disclosure document.


                                       29
I

103D CONGRESS

1ST SESSION H. R. 2169

To amend the Federal Food, Drug, and Cosmetic Act to require that foods

derived from plant varieties developed by methods of genetic modification

be labeled to identify their derivation.

IN THE HOUSE OF REPRESENTATIVES

MAY 19, 1993

Mr. KLECZKA introduced the following bill; which was referred to the

Committee on Energy and Commerce

A BILL

To amend the Federal Food, Drug, and Cosmetic Act to

require that foods derived from plant varieties developed

by methods of genetic modification be labeled to identify

their derivation.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. LABELING.

4 Section 403 of the Federal Food, Drug, and Cosmetic

5 Act (21 U.S.C. 343) is amended by adding at the end the

6 following:

7 ‘‘(s)(1) If it is derived from a plant variety which has

8 been developed by methods of genetic modification unless
2

•HR 2169 IH

1 it is labeled in accordance with regulations of the Sec2 retary to identify the food as being so derived.

3 ‘‘(2) For purposes of paragraph (1)—

4 ‘‘(A) the term ‘variety’ describes a subgroup of

5 plants (whether varieties or cultivars) within a spe6 cies developed for desirable traits,

7 ‘‘(B) the term ‘modification’ means the major

8 or minor alteration in the composition of food that

9 results from adding, deleting, or changing hereditary

10 traits, irrespective of the method, and

11 ‘‘(C) the term ‘genetic modification’ means the

12 alteration of the genotype of a plant using any tech13 nique whether new or traditional.’’.

14 SEC. 2. REGULATIONS AND EFFECTIVE DATE.

15 (a) REGULATIONS.—The Secretary of Health and

16 Human Services shall issue proposed regulations to imple17 ment section 403(s) of the Federal Food, Drug, and Cos18 metic Act (as added by section 1) not later than 6 months

19 after the date of the enactment of this Act. Within 6

20 months of the date proposed regulations are published in

21 the Federal Register, the Secretary shall issue final regu22 lations. If the Secretary does not issue final regulations

23 upon the expiration of such 12 months, the Congress finds

24 that there is good cause for the proposed regulations to

25 be considered final regulations without response to com-
3

•HR 2169 IH

1 ment because the implementation of the section with re2 spect to which such regulations were proposed is essential

3 to protect the public health. Consequently in such event,

4 the proposed regulations shall become the final regula5 tions. There shall be promptly published in the Federal

6 Register a notice of the new status of the proposed regula7 tions. If the proposed regulations become final under this

8 subparagraph, the Secretary shall complete the rule9 making begun with such proposed regulations.

10 (b) EFFECTIVE DATE.—The amendment made by

11 section 1 shall take effect on the date regulations under

12 subsection (a) become final.

Æ
```

[Congressional Bills 103th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1779 Engrossed Amendment House (EAH)]

                In the House of Representatives, U. S.,

                                                    September 19, 1994.
      Resolved, That the House agree to the amendments of the Senate to 
the bill (H.R. 1779) entitled ``An Act to designate the facility of the 
United States Postal Service located at 401 South Washington Street in 
Chillicothe, Missouri, as the `Jerry Litton United States Post Office 
Building''', with the following

                              AMENDMENTS:

 (1) Page 3, lines 3 and 4, strike out [proceeding], and insert: 
preceding

 (2) Page 4, line 3, strike out [section 1], and insert: section 4

            Attest:

                                                                 Clerk.
103d CONGRESS

  2d Session

                               H. R. 1779

_______________________________________________________________________

                               AMENDMENTS

                                   TO

                           SENATE AMENDMENTS
```
IN THE SUPREME COURT OF THE STATE OF MONTANA

No. DA 21-0133

STATE OF MONTANA,

Plaintiff and Appellee,

v.

CHARLES ANDREW DRURY,

Defendant and Appellant.

ORDER

Upon consideration of Appellant’s motion for extension of time, and 

good cause appearing,

IT IS HEREBY ORDERED that Appellant is granted an extension 

of time to and including August 25, 2021, within which to prepare, file, 

and serve Appellant’s opening brief on appeal.

Electronically signed by:

Mike McGrath

Chief Justice, Montana Supreme Court

July 20 2021

07/20/2021

Case Number: DA 21-0133
<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0000828747
<NAME> DRUG SCREENING SYSTEMS, INC.
<MULTIPLIER> 1
       
<S>                             <C>                     <C>
<PERIOD-TYPE>                   9-MOS                   3-MOS
<FISCAL-YEAR-END>                          JUN-30-1997             DEC-31-1996
<PERIOD-START>                             JUL-01-1997             JAN-01-1997
<PERIOD-END>                               MAR-31-1997             MAR-31-1997
<CASH>                                          91,754                       0
<SECURITIES>                                         0                       0
<RECEIVABLES>                                  171,202                       0
<ALLOWANCES>                                  (50,000)                       0
<INVENTORY>                                    409,942                       0
<CURRENT-ASSETS>                               731,502                       0
<PP&E>                                         919,107                       0
<DEPRECIATION>                               (665,862)                       0
<TOTAL-ASSETS>                               1,017,374                       0
<CURRENT-LIABILITIES>                          716,680                       0
<BONDS>                                              0                       0
<PREFERRED-MANDATORY>                           42,460                       0
<PREFERRED>                                          0                       0
<COMMON>                                        42,460                       0
<OTHER-SE>                                     343,154                       0
<TOTAL-LIABILITY-AND-EQUITY>                 1,017,374                       0
<SALES>                                      1,587,562                 478,864
<TOTAL-REVENUES>                             1,587,530                 478,864
<CGS>                                          837,931                 208,536
<TOTAL-COSTS>                                1,118,712                 330,267
<OTHER-EXPENSES>                                     0                       0
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                   0                       0
<INCOME-PRETAX>                              (369,113)                (59,939)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                          (369,113)                (59,939)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                 (369,113)                (59,939)
<EPS-PRIMARY>                                   (0.09)                  (0.01)
<EPS-DILUTED>                                   (0.09)                  (0.01)
        


</TABLE>
I

103D CONGRESS

1ST SESSION H. R. 2213

To provide that excess amounts from official allowances of Members of the

House of Representatives be returned to the Treasury for deficit reduction or for the purpose of making the amounts available for small

business loans and investments.

IN THE HOUSE OF REPRESENTATIVES

MAY 20, 1993

Mr. FRANKS of Connecticut introduced the following bill; which was referred

to the Committee on House Administration

A BILL

To provide that excess amounts from official allowances of

Members of the House of Representatives be returned

to the Treasury for deficit reduction or for the purpose

of making the amounts available for small business loans

and investments.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,
2

•HR 2213 IH

1 SECTION 1. EXCESS AMOUNTS FROM OFFICIAL ALLOW2 ANCES OF MEMBERS OF THE HOUSE OF REP3 RESENTATIVES TO BE RETURNED TO THE

4 TREASURY FOR DEFICIT REDUCTION OR FOR

5 DEPOSIT IN THE BUSINESS LOAN AND IN6 VESTMENT FUND.

7 Notwithstanding any other law, or any rule or other

8 authority, any amount remaining in an official allowance

9 of a Member of the House of Representatives at the end

10 of the session of Congress or other period for which the

11 allowance is made available shall be returned to the Treas12 ury for deficit reduction or for deposit in the business loan

13 and investment fund established by section 4(c)(1) of the

14 Small Business Act, as designated by the Member

15 involved.

16 SEC. 2. DEFINITIONS.

17 As used in this Act—

18 (1) the term ‘‘Member of the House of Rep19 resentatives’’ means a Representative in, or a Dele20 gate or Resident Commissioner to, the Congress;

21 and

22 (2) the term ‘‘official allowance’’ means, with

23 respect to a Member of the House of Representa24 tives, the Clerk Hire Allowance, the Official Ex25 penses Allowance, or the Official Mail Allowance.

Æ
I

★★

103D CONGRESS

1ST SESSION H. R. 1981

To amend the Employee Retirement Income Security Act of 1974 to clarify

the treatment of a qualified football coaches plan.

IN THE HOUSE OF REPRESENTATIVES

MAY 5, 1993

Mr. BREWSTER (for himself, Mr. MCCRERY, Mr. MCDERMOTT, Mr. CAMP,

Mr. BUNNING, Mr. JACOBS, Mr. CRANE, Mr. SUNDQUIST, Mr. PAXON,

and Mr. THOMAS of California) introduced the following bill; which was

referred to the Committee on Ways and Means

A BILL

To amend the Employee Retirement Income Security Act

of 1974 to clarify the treatment of a qualified football

coaches plan.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled:

3 SECTION 1. SHORT TITLE.

4 (a) SHORT TITLE.—This Act may be cited as the

5 ‘‘Qualified Football Coaches Plan Technical Corrections

6 Act of 1993.’’
2

HR 1981 IH2S

1 SEC. 2. CLARIFICATIONS OF PUBLIC LAW 100–202.

2 Section 1022 of title II of the Employee Retirement

3 Income Security Act of 1974 is amended by adding at the

4 end thereof the following new subsection:

5 ‘‘(l) QUALIFIED FOOTBALL COACHES PLAN.—For

6 purposes of determining the qualified plan status of a

7 qualified football coaches plan, section 3(37)(F) shall be

8 treated as part of this title and a qualified football coaches

9 plan shall be treated as a multiemployer collectively bar10 gained plan for purposes of title II the Employee Retire11 ment Income Security Act of 1974.’’

12 SEC. 3. EFFECTIVE DATE.

13 The amendment made by this Act shall apply to years

14 beginning after the enactment of Public Law 100–202.

Æ
Exhibit 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Annual Report of The National Bank of Indianapolis
Corporation (the "Company") on Form 10-K for the period ending December 31, 2003
as filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, Debra L. Ross, Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

    (3) The Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

    (4) The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the Company.


/s/ Debra L. Ross
-----------------------
Debra L. Ross
Chief Financial Officer
March 26, 2004


The foregoing certification is being furnished solely pursuant to 18 U.S.C.
Section 1350 and not for any other purpose, and is subject to the knowledge
standard contained in 18 U.S.C. Section 1350.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> UT
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               MAR-31-1997
<BOOK-VALUE>                                  PER-BOOK
<TOTAL-NET-UTILITY-PLANT>                   44,834,155
<OTHER-PROPERTY-AND-INVEST>                          0
<TOTAL-CURRENT-ASSETS>                       8,687,430
<TOTAL-DEFERRED-CHARGES>                     4,124,661
<OTHER-ASSETS>                                       0
<TOTAL-ASSETS>                              57,646,246
<COMMON>                                        11,156
<CAPITAL-SURPLUS-PAID-IN>                   19,376,264
<RETAINED-EARNINGS>                          2,659,699
<TOTAL-COMMON-STOCKHOLDERS-EQ>              20,969,680
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<LONG-TERM-DEBT-NET>                        10,169,113
<SHORT-TERM-NOTES>                             667,000
<LONG-TERM-NOTES-PAYABLE>                    5,442,000
<COMMERCIAL-PAPER-OBLIGATIONS>                       0
<LONG-TERM-DEBT-CURRENT-PORT>                3,460,113
<PREFERRED-STOCK-CURRENT>                            0
<CAPITAL-LEASE-OBLIGATIONS>                  2,755,291
<LEASES-CURRENT>                                78,367
<OTHER-ITEMS-CAPITAL-AND-LIAB>              14,104,682
<TOT-CAPITALIZATION-AND-LIAB>               57,646,246
<GROSS-OPERATING-REVENUE>                    9,915,335
<INCOME-TAX-EXPENSE>                           305,200
<OTHER-OPERATING-EXPENSES>                   8,506,429
<TOTAL-OPERATING-EXPENSES>                   8,811,629
<OPERATING-INCOME-LOSS>                      1,103,706
<OTHER-INCOME-NET>                            (15,913)
<INCOME-BEFORE-INTEREST-EXPEN>               1,127,693
<TOTAL-INTEREST-EXPENSE>                       405,731
<NET-INCOME>                                   721,962
<PREFERRED-STOCK-DIVIDENDS>                          0
<EARNINGS-AVAILABLE-FOR-COMM>                  721,962
<COMMON-STOCK-DIVIDENDS>                       433,257
<TOTAL-INTEREST-ON-BONDS>                      828,125
<CASH-FLOW-OPERATIONS>                       2,177,186
<EPS-PRIMARY>                                     0.45
<EPS-DILUTED>                                     0.00
        

</TABLE>
I

103D CONGRESS

1ST SESSION H. R. 2085

To temporarily suspend the duty on N-[[(4-chlorophenyl)amino]carbonyl]-2-

difluorobenzamide, and for other purposes.

IN THE HOUSE OF REPRESENTATIVES

MAY 12, 1993

Mrs. JOHNSON of Connecticut (by request) introduced the following bill; which

was referred to the Committee on Ways and Means

A BILL

To temporarily suspend the duty on N-[[(4-

chlorophenyl)amino]carbonyl]-2-difluorobenzamide, and

for other purposes.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. TEMPORARY SUSPENSION OF DUTY.

4 (a) N-[[(4-CHLOROPHENYL)AMINO]CARBONYL]-2-

5 DIFLUOROBENZAMIDE.—Subchapter II of chapter 99 of

6 the Harmonized Tariff Schedule of the United States is

7 amended by inserting in numerical sequence the following

8 new heading:
2

•HR 2085 IH

‘‘ 9902.31.12 N-[[(4-chlorophenyl)-

amino]carbonyl]-2-

difluorobenzamide

(diflubenzuron) (provided for

in subheading 2924.29.19) ... Free No change No change On or before

12/31/98 ’’.

1 (b) N-[[(4-CHLOROPHENYL)AMINO]CARBONYL]-2-

2 DIFLUOROBENZAMIDE AND INERTS.—Subchapter II of

3 chapter 99 of the Harmonized Tariff Schedule of the Unit4 ed States is amended by inserting in numerical sequence

5 the following new heading:

‘‘ 9902.38.13 Mixtures of N-[[(4-

chlorophenyl)amino]-

carbonyl]-2-difluorobenzamide (diflubenzuron)

and inert substances (provided for in subheading

3808.10.20) .......................... Free No change No change On or before

12/31/98 ’’.

6 (c) EFFECTIVE DATE.—The amendments made by

7 subsections (a) and (b) apply with respect to goods en8 tered, or withdrawn from warehouse for consumption, on

9 or after the 15th day after the date of the enactment of

10 this Act.

Æ
United States Court of Appeals 

for the Fifth Circuit 

No. 21-50012 

Vinay Yadav, 

Plaintiff—Appellant, 

versus

Frost Bank, 

Defendant—Appellee. 

Appeal from the United States District Court 

for the Western District of Texas 

USDC No. 5:20-CV-005 

Before Higginbotham, Jones, and Costa, Circuit Judges.

Per Curiam:*

This case arises out of Frost Bank’s termination of Vinay Yadav and 

its alleged use of the San Antonio Police Department to remove him from 

bank premises. Adopting a thorough opinion of the magistrate judge, the 

district court dismissed Yadav’s claims for retaliatory discharge, defamation, 

RICO, and intentional infliction of emotional distress. The court denied the 

*

 Pursuant to 5th Circuit Rule 47.5, the court has determined that this 

opinion should not be published and is not precedent except under the limited 

circumstances set forth in 5th Circuit Rule 47.5.4. 

United States Court of Appeals 

Fifth Circuit 

FILED 

June 29, 2021 

Lyle W. Cayce 

Clerk 

Case: 21-50012 Document: 00515918452 Page: 1 Date Filed: 06/29/2021
No. 21-50012 

2 

motion to dismiss his assault claim and remanded that claim to state court as 

the RICO dismissal meant there was no longer a federal claim in the case. See 

28 U.S.C. § 1367(c). 

Yadav appeals the dismissal of his claims. Having reviewed the briefs, 

Yadav’s pleadings, and the applicable law, we agree with the court’s 

dismissal of all but the assault claim essentially for the reasons stated in the 

magistrate judge’s opinion. Yadav’s brief also discusses the assault claim, 

but that claim was appropriately sent back to state court. As a result, we have 

no basis for considering Yadav’s arguments relating to the assault claim. 

Affirmed. 

Case: 21-50012 Document: 00515918452 Page: 2 Date Filed: 06/29/2021